Bio Green Med Solution, Inc. cash flow to debt ratio of -238.50K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Bio Green Med Solution, Inc.'s free cash flow has increased -40.30% from $-7.99M last year to $-4.77M, signaling increasing performance

Bio Green Med Solution, Inc.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.

Bio Green Med Solution, Inc. has insufficient data to evaluate this check.

Bio Green Med Solution, Inc. has a net cash position, so leverage is healthy.

Bio Green Med Solution, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Bio Green Med Solution, Inc.'s profit margin has increased (-99.22%) in the last year from -26.07K% to -204.20%, signaling increasing performance

Bio Green Med Solution, Inc.'s short-term assets of $6.26M exceed its short-term liabilities of $1.33M

Bio Green Med Solution, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Bio Green Med Solution, Inc.'s return on equity of -51.20%, is lower than 15.00%, indicating bad performance

Bio Green Med Solution, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Bio Green Med Solution, Inc. has insufficient public price history to evaluate earnings stability.

Bio Green Med Solution, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Bio Green Med Solution, Inc. has negative free cash flow, indicating cash burn

Bio Green Med Solution, Inc.'s yearly earnings has increased -73.26% since last year from $-11.21M to $-3.00M, signaling increasing performance

Bio Green Med Solution, Inc.'s yearly revenue has increased 1.64K% since last year from $43.00K to $747.00K, signaling increasing performance

ROIC -53.74% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Bio Green Med Solution, Inc. has insufficient revenue history to calculate 3-year revenue CAGR.

Bio Green Med Solution, Inc. has insufficient public price history to evaluate revenue consistency.

Bio Green Med Solution, Inc. has insufficient public price history to evaluate ROE consistency.

Bio Green Med Solution, Inc. has insufficient data to evaluate this check.

Bio Green Med Solution, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Bio Green Med Solution, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Bio Green Med Solution, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Bio Green Med Solution, Inc. has insufficient data to evaluate this check.

Bio Green Med Solution, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Bio Green Med Solution, Inc. has a price-to-book ratio of 0.73x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Bio Green Med Solution, Inc. has a price-to-sales ratio of 3.22x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue